These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 27141426)

  • 21. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
    Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
    Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
    Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
    J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.
    Tosi G; Duskey JT; Kreuter J
    Expert Opin Drug Deliv; 2020 Jan; 17(1):23-32. PubMed ID: 31774000
    [No Abstract]   [Full Text] [Related]  

  • 24. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
    Greene C; Campbell M
    Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease.
    Fu L; Chung R; Shi B
    Methods Mol Biol; 2019; 2054():263-282. PubMed ID: 31482461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.
    Pandey PK; Sharma AK; Gupta U
    Tissue Barriers; 2016; 4(1):e1129476. PubMed ID: 27141418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in nanomedicines for diagnosis of central nervous system disorders.
    Zhang X; Zhou J; Gu Z; Zhang H; Gong Q; Luo K
    Biomaterials; 2021 Feb; 269():120492. PubMed ID: 33153757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.
    Fan K; Jia X; Zhou M; Wang K; Conde J; He J; Tian J; Yan X
    ACS Nano; 2018 May; 12(5):4105-4115. PubMed ID: 29608290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting specific cells in the brain with nanomedicines for CNS therapies.
    Zhang F; Lin YA; Kannan S; Kannan RM
    J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
    Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanotechnology-based drug delivery for central nervous system disorders.
    Nguyen TT; Dung Nguyen TT; Vo TK; Tran NM; Nguyen MK; Van Vo T; Van Vo G
    Biomed Pharmacother; 2021 Nov; 143():112117. PubMed ID: 34479020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
    Ceña V; Játiva P
    Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
    [No Abstract]   [Full Text] [Related]  

  • 39. Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.
    Gidwani M; Singh AV
    Curr Pharm Biotechnol; 2014; 14(14):1201-12. PubMed ID: 24809717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered blood-brain barrier transport in neuro-inflammatory disorders.
    Schenk GJ; de Vries HE
    Drug Discov Today Technol; 2016 Jun; 20():5-11. PubMed ID: 27986224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.